Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT01065805
Eligibility Criteria:
Inclusion Criteria:
* Male or female greater than or equal to 16 years of age. If female of child-bearing potential and outside of the window of 10 days since the first day of last menstrual period, a negative pregnancy test is required.
* Patients with known primary or suspected primary, recurrent or metastatic carcinoma of the lung, breast, renal cell, pancreas or brain (including GGM, oligodendrogliomas, and brain metastases from any primary tumour) and with gastrointestinal malignancies, neuroendocrine tumours (including carcinoid and islet cell malignancies, or lymphoma, with at least one lesion \>1 cm in diameter.
* Biochemical parameters as measured are required to be within 5 times the normal limits for age.
* Able and willing to follow instruction and comply with the protocol
* Provide written informed consent prior to participation in the study
* Karnofsky Performance Scale Score 50-100
Exclusion Criteria:
* Previous removal of entire tumour
* Biochemical parameters as measured outside 5 times the normal limits for age
* Unable or unwilling to follow instructions and comply with the protocol
* Unable or unwilling to provide written informed consent prior to participation in the study
* Karnofsky Performance Scale Score \< 50
* Nursing or pregnant females
* Age less than 16 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT01065805
Study Brief:
Protocol Section:
NCT01065805